<p>Nutex Health Inc.（納斯達克代碼：NUTX - 獲取免費報告）在週二的交易中股價創下 52 周新高。該公司股價最高達到 187.20 美元，最後交易價格為 181.06 美元，交易量為 283744 股。該股票此前收盤價為 160.95 美元。</p>
<h2>分析師設定新目標價</h2>
<p>幾家研究公司最近對 NUTX 進行了評估。Maxim Group 在 8 月 26 日的研究報告中將 Nutex Health 的目標價設定為 205.00 美元，並給予該股票 “買入” 評級。Weiss Ratings 在 12 月 1 日的研究報告中重新發布了對 Nutex Health 股票的 “持有（c）” 評級。最後，Wall Street Zen 在 11 月 28 日的報告中將 Nutex Health 的評級從 “買入” 上調至 “強力買入”。兩位研究分析師對該股票給予了買入評級，一位則給予了持有評級。根據 MarketBeat.com 的數據，Nutex Health 目前的平均評級為 “適度買入”，平均目標價為 252.50 美元。</p>
<p><strong>閲讀我們關於 Nutex Health 的最新股票報告</strong></p>
<h2>Nutex Health 股價上漲 12.5%</h2>
<p>該公司的市值為 12.8 億美元，市盈率為 9.79，貝塔值為-0.03。該公司的 50 日簡單移動平均線為 118.38 美元，200 日簡單移動平均線為 111.96 美元。公司的流動比率為 3.20，速動比率為 3.18，債務與股本比率為 0.67。</p>
<p>Nutex Health（納斯達克代碼：NUTX - 獲取免費報告）最近於 11 月 18 日發佈了季度財報。該公司報告每股收益為 7.76 美元，超出市場共識預期的（5.43 美元）13.19 美元。Nutex Health 的股本回報率為 37.44%，淨利潤率為 11.62%。該公司在本季度的收入為 2.4399 億美元，而分析師的預期為 2.2193 億美元。</p>
<h2>內部人士活動</h2>
<p>在相關消息中，首席財務官 Jon Christian Bates 於 11 月 25 日購買了 750 股 Nutex Health 股票。該股票的平均購買成本為每股 136.71 美元，總交易額為 102,532.50 美元。購買完成後，首席財務官直接持有該公司 5,638 股股票，價值 770,770.98 美元。此次交易使其持股增加了 15.34%。該購買在向 SEC 的法律文件中披露，相關信息可通過 SEC 網站獲取。目前，36.92% 的股票由內部人士持有。</p>
<h2>機構投資者對 Nutex Health 的看法</h2>
<p>機構投資者和對沖基金最近增加或減少了對該股票的持股。美國銀行（Bank of America Corp DE）在第四季度將其在 Nutex Health 的持股增加了 6590.3%。美國銀行（Bank of America Corp DE）目前持有該公司 2,074 股股票，價值 66,000 美元，此前在上個季度又購買了 2,043 股。Informed Momentum Co LLC 在第一季度購買了 Nutex Health 的新股份，價值為 868,000 美元。American Century Companies Inc.在第一季度將其在 Nutex Health 的持股增加了 73.0%。American Century Companies Inc.目前持有 74,359 股該公司股票，價值為 3,497,000 美元，此前在該期間又收購了 31,366 股。OMERS ADMINISTRATION Corp 在第一季度將其在 Nutex Health 的持股增加了 28.8%。OMERS ADMINISTRATION Corp 目前持有 9,400 股該公司股票，價值為 442,000 美元，此前在上個季度又購買了 2,100 股。最後，高盛集團（Goldman Sachs Group Inc.）在第一季度將其在 Nutex Health 的持股增加了 17.9%。高盛集團（Goldman Sachs Group Inc.）目前持有 18,119 股該公司股票，價值為 852,000 美元，此前在上個季度又購買了 2,748 股。對沖基金和其他機構投資者持有該公司 5.32% 的股票。</p>
<h2>Nutex Health 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Nutex Health Inc.是一家由醫生主導的醫療服務和運營公司。它通過三個部門運營：醫院、人口健康管理（PHM）和房地產。PHM 部門建立並運營獨立的醫生協會；併為醫療組織提供基於雲的平台，以提供基於價值的護理和人口健康管理。</p>
<h2>精選文章</h2>
<ul>
<li>我們更看好的五隻股票，而不是 Nutex Health</li>
<li>股票平均計算器</li>
<li>Dollar Tree 的激增和 Home Depot 的下滑對消費者健康的影響</li>
<li>萬億美元市值的意義超越數字</li>
<li>2026 年最有可能拆分的三隻股票</li>
<li>外匯是什麼，它是如何運作的？</li>
<li>ChargePoint 的復甦故事：為什麼這隻電動車股票再次上漲</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Nutex Health 嗎？</h2>
<p>在考慮 Nutex Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前購買……而 Nutex Health 並不在名單上。</p>
<p>雖然 Nutex Health 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

NUTX

<p>Nutex Health（納斯達克代碼：NUTX）股票達到新的 52 周高點，交易價格高達 187.20 美元。分析師們設定了新的價格目標，Maxim Group 將其評級為 “買入”，目標價為 205.00 美元。機構投資者調整了他們的持股，美國銀行大幅增加了其持股。該公司報告了強勁的季度收益，超出預期，每股收益為 7.76 美元，收入為 2.4399 億美元。內部人士活動包括首席財務官 Jon Christian Bates 購買股票，增加了 15.34% 的持股比例。Nutex Health 專注於醫療服務，涵蓋醫院、PHM 和房地產領域</p>

<p>Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) shares hit a new 52-week high during trading on Tuesday . The company traded as high as $187.20 and last traded at $181.06, with a volume of 283744 shares traded. The stock had previously closed at $160.95.</p>
<div class="lb-trans"><p>Nutex Health Inc.（納斯達克代碼：NUTX - 獲取免費報告）在週二的交易中股價創下 52 周新高。該公司股價最高達到 187.20 美元，最後交易價格為 181.06 美元，交易量為 283744 股。該股票此前收盤價為 160.95 美元。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>Several research firms recently weighed in on NUTX. Maxim Group set a $205.00 price target on Nutex Health and gave the stock a &#34;buy&#34; rating in a research note on Tuesday, August 26th. Weiss Ratings reissued a &#34;hold (c)&#34; rating on shares of Nutex Health in a research note on Monday, December 1st. Finally, Wall Street Zen upgraded Nutex Health from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a report on Friday, November 28th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Nutex Health currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $252.50.</p>
<div class="lb-trans"><p>幾家研究公司最近對 NUTX 進行了評估。Maxim Group 在 8 月 26 日的研究報告中將 Nutex Health 的目標價設定為 205.00 美元，並給予該股票 “買入” 評級。Weiss Ratings 在 12 月 1 日的研究報告中重新發布了對 Nutex Health 股票的 “持有（c）” 評級。最後，Wall Street Zen 在 11 月 28 日的報告中將 Nutex Health 的評級從 “買入” 上調至 “強力買入”。兩位研究分析師對該股票給予了買入評級，一位則給予了持有評級。根據 MarketBeat.com 的數據，Nutex Health 目前的平均評級為 “適度買入”，平均目標價為 252.50 美元。</p>
</div><p><strong>Read Our Latest Stock Report on Nutex Health</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 Nutex Health 的最新股票報告</strong></p>
</div><h2>Nutex Health Trading Up 12.5%</h2>
<div class="lb-trans"><h2>Nutex Health 股價上漲 12.5%</h2>
</div><p>The firm has a market capitalization of $1.28 billion, a PE ratio of 9.79 and a beta of -0.03. The firm has a 50 day simple moving average of $118.38 and a 200 day simple moving average of $111.96. The company has a current ratio of 3.20, a quick ratio of 3.18 and a debt-to-equity ratio of 0.67.</p>
<div class="lb-trans"><p>該公司的市值為 12.8 億美元，市盈率為 9.79，貝塔值為-0.03。該公司的 50 日簡單移動平均線為 118.38 美元，200 日簡單移動平均線為 111.96 美元。公司的流動比率為 3.20，速動比率為 3.18，債務與股本比率為 0.67。</p>
</div><p>Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share for the quarter, topping the consensus estimate of ($5.43) by $13.19. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.The firm had revenue of $243.99 million during the quarter, compared to analysts' expectations of $221.93 million.</p>
<div class="lb-trans"><p>Nutex Health（納斯達克代碼：NUTX - 獲取免費報告）最近於 11 月 18 日發佈了季度財報。該公司報告每股收益為 7.76 美元，超出市場共識預期的（5.43 美元）13.19 美元。Nutex Health 的股本回報率為 37.44%，淨利潤率為 11.62%。該公司在本季度的收入為 2.4399 億美元，而分析師的預期為 2.2193 億美元。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部人士活動</h2>
</div><p>In related news, CFO Jon Christian Bates purchased 750 shares of Nutex Health stock in a transaction dated Tuesday, November 25th. The stock was purchased at an average cost of $136.71 per share, for a total transaction of $102,532.50. Following the completion of the purchase, the chief financial officer directly owned 5,638 shares of the company's stock, valued at $770,770.98. The trade was a 15.34% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 36.92% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在相關消息中，首席財務官 Jon Christian Bates 於 11 月 25 日購買了 750 股 Nutex Health 股票。該股票的平均購買成本為每股 136.71 美元，總交易額為 102,532.50 美元。購買完成後，首席財務官直接持有該公司 5,638 股股票，價值 770,770.98 美元。此次交易使其持股增加了 15.34%。該購買在向 SEC 的法律文件中披露，相關信息可通過 SEC 網站獲取。目前，36.92% 的股票由內部人士持有。</p>
</div><h2>Institutional Investors Weigh In On Nutex Health</h2>
<div class="lb-trans"><h2>機構投資者對 Nutex Health 的看法</h2>
</div><p>Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Bank of America Corp DE raised its stake in Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after buying an additional 2,043 shares during the last quarter. Informed Momentum Co LLC purchased a new stake in Nutex Health during the first quarter valued at $868,000. American Century Companies Inc. lifted its holdings in Nutex Health by 73.0% in the first quarter. American Century Companies Inc. now owns 74,359 shares of the company's stock valued at $3,497,000 after acquiring an additional 31,366 shares during the period. OMERS ADMINISTRATION Corp boosted its position in Nutex Health by 28.8% in the first quarter. OMERS ADMINISTRATION Corp now owns 9,400 shares of the company's stock worth $442,000 after purchasing an additional 2,100 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in Nutex Health by 17.9% in the first quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company's stock worth $852,000 after purchasing an additional 2,748 shares during the last quarter. Hedge funds and other institutional investors own 5.32% of the company's stock.</p>
<div class="lb-trans"><p>機構投資者和對沖基金最近增加或減少了對該股票的持股。美國銀行（Bank of America Corp DE）在第四季度將其在 Nutex Health 的持股增加了 6590.3%。美國銀行（Bank of America Corp DE）目前持有該公司 2,074 股股票，價值 66,000 美元，此前在上個季度又購買了 2,043 股。Informed Momentum Co LLC 在第一季度購買了 Nutex Health 的新股份，價值為 868,000 美元。American Century Companies Inc.在第一季度將其在 Nutex Health 的持股增加了 73.0%。American Century Companies Inc.目前持有 74,359 股該公司股票，價值為 3,497,000 美元，此前在該期間又收購了 31,366 股。OMERS ADMINISTRATION Corp 在第一季度將其在 Nutex Health 的持股增加了 28.8%。OMERS ADMINISTRATION Corp 目前持有 9,400 股該公司股票，價值為 442,000 美元，此前在上個季度又購買了 2,100 股。最後，高盛集團（Goldman Sachs Group Inc.）在第一季度將其在 Nutex Health 的持股增加了 17.9%。高盛集團（Goldman Sachs Group Inc.）目前持有 18,119 股該公司股票，價值為 852,000 美元，此前在上個季度又購買了 2,748 股。對沖基金和其他機構投資者持有該公司 5.32% 的股票。</p>
</div><h2>Nutex Health Company Profile</h2>
<div class="lb-trans"><h2>Nutex Health 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.</p>
<div class="lb-trans"><p>Nutex Health Inc.是一家由醫生主導的醫療服務和運營公司。它通過三個部門運營：醫院、人口健康管理（PHM）和房地產。PHM 部門建立並運營獨立的醫生協會；併為醫療組織提供基於雲的平台，以提供基於價值的護理和人口健康管理。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Nutex Health</li>
<li>Stock Average Calculator</li>
<li>What Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer Health</li>
<li>The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number</li>
<li>3 Stocks Most Likely to Split in 2026</li>
<li>What is Forex and How Does it Work?</li>
<li>ChargePoint's Comeback Story: Why This EV Stock Is Charging Up Again</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而不是 Nutex Health</li>
<li>股票平均計算器</li>
<li>Dollar Tree 的激增和 Home Depot 的下滑對消費者健康的影響</li>
<li>萬億美元市值的意義超越數字</li>
<li>2026 年最有可能拆分的三隻股票</li>
<li>外匯是什麼，它是如何運作的？</li>
<li>ChargePoint 的復甦故事：為什麼這隻電動車股票再次上漲</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Nutex Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Nutex Health 嗎？</h2>
</div><p>Before you consider Nutex Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Nutex Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前購買……而 Nutex Health 並不在名單上。</p>
</div><p>While Nutex Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Nutex Health 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Nutex Health（NASDAQ:NUTX）創下新的 1 年高點 - 事情經過如下